Dergiler / Marmara Medical Journal / 2022 / Cilt: 35 - Sayı: 1

The relationship between abdominal obesity and irritable bowel syndrome in adults

Sayfa
31–35
Yayın Tarihi
2022-01-31
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: In this study no statistically significant relationship has been detected between IBS and abdominal obesity.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The aim of this study is to evaluate the relationship between irritable bowel syndrome (IBS) and abdominal obesity.
📊
Temel Bulgular & Veri:Patients and Methods: This is a cross-sectional study, consisting of 18-49 year old patients who applied to Marmara University School of Medicine’s Family Medicine outpatient clinics and who accepted to participate.
💡
Sonuç & Katkı:Conclusion: In this study no statistically significant relationship has been detected between IBS and abdominal obesity.
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Irritable bowel syndrome · Abdominal obesity · Central obesity

Abstract

Objective: The aim of this study is to evaluate the relationship between irritable bowel syndrome (IBS) and abdominal obesity. Patients and Methods: This is a cross-sectional study, consisting of 18-49 year old patients who applied to Marmara University School of Medicine’s Family Medicine outpatient clinics and who accepted to participate. A questionnaire was applied using face-to-face interview technique; anthropometric measurements were obtained as recommended by World Health Organization (WHO). The diagnosis of IBS was made for those who fully met the diagnostic criteria of ROME IV-IBS and had no alarm symptoms. Abdominal obesity of the participants was determined via anthropometric measurements. Statistical analyses were performed by using SPSS 20 package program. Results: A total of 487 patients participated in the study: 77% female, 33% male; mean age value 33.71±8.59 years. The prevalence of IBS was 24.2% (n=118) [F:27.2% (n=102), M:14.3% (n=16)]. Abdominal obesity prevalence was 31.2% (n=152) [F:24.5% (n=92, M:53.6% (n=60)]. There is no statistically significant difference in terms of abdominal obesity with and without IBS (p>0.05). Conclusion: In this study no statistically significant relationship has been detected between IBS and abdominal obesity.

🔖

Bu Makaleye Atıf Yap

KAYA, Y. D., UZUNER, A. (2022). The relationship between abdominal obesity and irritable bowel syndrome in adults. Marmara Medical Journal, Cilt: 35 - Sayı: 1, 31–35. https://ajindex.com/articles/688272

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

  1. Heidelbaugh J, Hungin P, Guest Eds, editors. Drossman DA, Chang L, Kellow J, Chey WD, Tack J, Whitehead WE, editors. The Rome IV Primary Care Committee. Rome IV functional gastrointestinal disorders for primary care and non-GI clinicians. 1st ed. Raleigh, NC: The Rome Foundation, 2016.
  2. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712-1. doi:10.1016/j.cgh.2012.02.029 Celebi S, Acik Y, Deveci SE, et al.Epidemiological features of irritable bowel syndrome in a Turkish urban society. J Gastroenterol Hepatol 2004;19:738-43. doi: 10.1111/j.1400- 1746.2004.03367.x Özden A, Köksal ŞA, Oğuz D, et al. Türkiye’de birinci basamak sağlık kurumlarında irritabl barsak sendromu görülme sıklığı. Akademik Gastroenteroloji Dergisi 2006; 5: 4-15.
  3. Lee OY, Mayer EA, Schmulson M, Chang L, Naliboff B. Genderrelated differences in IBS symptoms. Am J Gastroenterol 2001;96:2184-93. doi:10.1016/S0002-9270(01)02524-2
  4. Bennett G, Talley NJ. Irritable bowel syndrome in the elderly. Best Pract Res Clin Gastroenterol 2002;16:63-76. doi:10.1053/ bega.2001.02661 Longstreth GF, Wilson A, Knight K, et al. Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol 2003;98:600-7. doi:10.1016/ S0002-9270(02)06018-5
  5. Obezite, T. E. M. D., ve Hipertansiyon Çalışma Grubu. Obezite tanı ve tedavi kılavuzu. Türkiye Endokrinoloji ve Metabolizma Derneği. Ankara: Tıpkı Basım, 2017: 11-19.
  6. Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28:169-80. doi: 10.1007/ s10654.013.9771-5 World Health Organization. Waist circumference and waisthip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008. World Health Organization 2011. Available at: https://apps.who.int/iris/handle/10665/44583 Accessed on: 27.09.2021
  7. Balkau B, Deanfield JE, Després JP, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007;116:1942-51. doi: 10.1161/circulationaha.106.676379 John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA. Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther 2006;23: 1511-23. doi: 10.1111/j.1365-2036.2006.02915.x Liu P, Ma F, Lou H, Liu Y.The